Research involving nearly 1 million US veterans identifies the combination of insomnia and obstructive sleep apnea as a distinct risk state for hypertension and cardiovascular disease.
Read More
Voice recordings from mobile memory tests allowed investigators to predict subjective sleepiness in older adults with strong accuracy, suggesting a practical screening tool outside the clinic.
Read More
Data from 30,000 respondents shows that while most value sleep over diet and exercise, more than half fail to get consistent rest.
Read More
The Swiss biotech company expects a pediatric insomnia study readout in 2026.
Read More
With the acquisition of Avadel Pharmaceuticals complete, Alkermes prepares to initiate phase 3 studies for its orexin agonist alixorexton while planning a leadership transition for mid-2026.
Read More